<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04559880</url>
  </required_header>
  <id_info>
    <org_study_id>6029804</org_study_id>
    <nct_id>NCT04559880</nct_id>
  </id_info>
  <brief_title>Tranexamic Acid to Prevent Bleeding After Endoscopic Resection of Large Colorectal Polyps: A Pilot Project</brief_title>
  <official_title>Tranexamic Acid to Prevent Bleeding After Endoscopic Resection of Large Colorectal Polyps: A Pilot Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colorectal cancer is the second most common cancer in Canada. Colonoscopy and removal of&#xD;
      precancerous polyps (polypectomy) reduces the incidence and mortality associated with&#xD;
      colorectal cancer. However, polypectomy is associated with adverse events. Post-polypectomy&#xD;
      bleeding has a significant impact on the life of the patient as it can require&#xD;
      hospitalization, transfusions, repeat colonoscopy and rarely death. It is also a substantial&#xD;
      cost to the health care system. There currently is no standard of care to prevent bleeding&#xD;
      after polypectomy.&#xD;
&#xD;
      Tranexamic acid reduces fibrinolysis by slowing down the conversion of plasminogen to plasmin&#xD;
      which may prevent bleeding. Although this medication is used extensively for other purposes,&#xD;
      it has not been studied before to prevent post-polypectomy bleeding.&#xD;
&#xD;
      This pilot study will examine factors involved in the feasibility of conducting a large-scale&#xD;
      randomized controlled trial (RCT). This pilot study will include 25 consecutive patients who&#xD;
      are treated with tranexamic acid after endoscopic mucosal resection (EMR) of large&#xD;
      non-pedunculated colorectal polyps (LNPCP's) to prevent PPDB.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colorectal cancer is the second most common cancer in Canada. Colonoscopy and removal of&#xD;
      precancerous polyps (polypectomy) reduces the incidence and mortality associated with&#xD;
      colorectal cancer. However, polypectomy is associated with adverse events. Post-polypectomy&#xD;
      bleeding has a significant impact on the life of the patient as it can require&#xD;
      hospitalization, transfusions, repeat colonoscopy and rarely death. It is also a substantial&#xD;
      cost to the health care system. Post-polypectomy delayed bleeding (PPDB) can occur up to a&#xD;
      month following the procedure but is typically seen within the first week. Risk factors&#xD;
      include the size of the polyp, antithrombotic or anticoagulation use, age, major&#xD;
      comorbidities and proximal colon polyps. The incidence of bleeding after removal of large&#xD;
      polyps is estimated to be around 2.6%-9.7%. There currently is no standard of care to prevent&#xD;
      bleeding after polypectomy. Tranexamic acid reduces fibrinolysis by slowing down the&#xD;
      conversion of plasminogen to plasmin which may prevent bleeding.&#xD;
&#xD;
      This pilot study will examine factors involved in the feasibility of conducting a large-scale&#xD;
      RCT. This pilot study will include 25 consecutive patients who are treated with tranexamic&#xD;
      acid after endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps&#xD;
      (LNPCP's) to prevent PPDB.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2020</start_date>
  <completion_date type="Anticipated">November 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 10, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>25 consecutive patients treated with tranexamic acid after endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps (LNPCP's) to prevent post-polypectomy delayed bleeding (PPDB).</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Enrollment frequency</measure>
    <time_frame>Through study completion, an average of 6 months</time_frame>
    <description>How many participants are enrolled each week</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Study drug compliance rates</measure>
    <time_frame>Through study completion, an average of 6 months</time_frame>
    <description>Number of participants that receive the intravenous tranexamic acid within 2 hours of polyp removal and the number of participants that receive every scheduled dose of the tranexamic acid at home</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recruitment rates</measure>
    <time_frame>Through study completion, an average of 6 months</time_frame>
    <description>How many eligible patients decide to participate in the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Follow-up rates</measure>
    <time_frame>Through study completion, an average of 6 months</time_frame>
    <description>How many participants complete all follow-up phone calls</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>How many participants experience thromboembolic events, perforation and post-polypectomy electrocoagulation syndrome, seizure activity and vision changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-procedure bleeding</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>How many participants experience severe bleeding event that requires hospitalization, transfusion, colonoscopy, surgery or another invasive intervention within 30 days after completion of the colonoscopy with polypectomy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Polyp, Colorectal</condition>
  <arm_group>
    <arm_group_label>Tranexamic Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intra-procedural tranexamic acid (TXA) - 1 gram, IV&#xD;
Post-procedural tranexamic acid (TXA) - 1 gram, oral, three times per day for 5 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid Injection [Cyklokapron]</intervention_name>
    <description>Intra-procedurally, participants will receive 1 gram of intravenous tranexamic acid immediately following the polypectomy. Participants will also take oral tranexamic acid tablets (three times per day) at home for the five days following the procedure.</description>
    <arm_group_label>Tranexamic Acid</arm_group_label>
    <other_name>Tranexamic Acid Oral Tablets [Cyklokapron]</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients aged over 18 who have non-pedunculated colorectal polyps,&#xD;
&#xD;
          2. Polyps ≥2cm,&#xD;
&#xD;
          3. Polyps removed by endoscopic mucosal resection (EMR),&#xD;
&#xD;
          4. Agree to be followed up by phone,&#xD;
&#xD;
          5. Ability to read and understand the English language.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who have inflammatory bowel disease,&#xD;
&#xD;
          2. Diagnosed bleeding disorder,&#xD;
&#xD;
          3. Ulcerated morphology of polyps or those with proven invasive cancer,&#xD;
&#xD;
          4. Patients with a history of or are at higher risk of thromboembolic events (atrial&#xD;
             fibrillation on anticoagulation, history of stroke, transient ischemic attack (TIA),&#xD;
             pulmonary embolism, deep vein thrombosis, hypercoagulable state, oral contraceptive&#xD;
             pill (OCP) or hormone replacement therapy use, mechanical heart valve on&#xD;
             anticoagulation, myocardial infarction in the last twelve months, retinal vein or&#xD;
             retinal artery occlusion),&#xD;
&#xD;
          5. Unable to provide follow up,&#xD;
&#xD;
          6. Unable to provide consent,&#xD;
&#xD;
          7. Pregnancy,&#xD;
&#xD;
          8. Patients undergoing endoscopic submucosal dissection (ESD),&#xD;
&#xD;
          9. Seizure disorder,&#xD;
&#xD;
         10. Ureteral obstruction within past 6 months,&#xD;
&#xD;
         11. Subarachnoid hemorrhage within past 6 months,&#xD;
&#xD;
         12. A diagnosed acquired defective colour vision disorder.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Bechara, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melinda Allen</last_name>
    <phone>613-544-3400</phone>
    <phone_ext>3885</phone_ext>
    <email>melinda.allen@kingstonhsc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aline Costa da Silva Asselstine</last_name>
    <phone>613-544-3400</phone>
    <phone_ext>3421</phone_ext>
    <email>aline.costadasilvaasselstine@kingstonhsc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kingston Health Sciences Centre - Hotel Dieu Hospital Site</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 5G2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Allen</last_name>
      <phone>613-544-3400</phone>
      <phone_ext>3385</phone_ext>
      <email>melinda.allen@kingstonhsc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Aline Costa da Silva Asselstine</last_name>
      <phone>613-544-3400</phone>
      <phone_ext>3421</phone_ext>
      <email>aline.costadasilvaasselstine@kingstonhsc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Bechara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lawrence Hookey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula James, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mandip Rai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, Imamura Y, Willett WC, Rosner BA, Fuchs CS, Giovannucci E, Ogino S, Chan AT. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013 Sep 19;369(12):1095-105. doi: 10.1056/NEJMoa1301969.</citation>
    <PMID>24047059</PMID>
  </results_reference>
  <results_reference>
    <citation>ASGE Standards of Practice Committee, Fisher DA, Maple JT, Ben-Menachem T, Cash BD, Decker GA, Early DS, Evans JA, Fanelli RD, Fukami N, Hwang JH, Jain R, Jue TL, Khan KM, Malpas PM, Sharaf RN, Shergill AK, Dominitz JA. Complications of colonoscopy. Gastrointest Endosc. 2011 Oct;74(4):745-52. doi: 10.1016/j.gie.2011.07.025. Erratum in: Gastrointest Endosc. 2016 Nov;84(5):883.</citation>
    <PMID>21951473</PMID>
  </results_reference>
  <results_reference>
    <citation>Albéniz E, Fraile M, Ibáñez B, Alonso-Aguirre P, Martínez-Ares D, Soto S, Gargallo CJ, Ramos Zabala F, Álvarez MA, Rodríguez-Sánchez J, Múgica F, Nogales Ó, Herreros de Tejada A, Redondo E, Pin N, León-Brito H, Pardeiro R, López-Roses L, Rodríguez-Téllez M, Jiménez A, Martínez-Alcalá F, García O, de la Peña J, Ono A, Alberca de Las Parras F, Pellisé M, Rivero L, Saperas E, Pérez-Roldán F, Pueyo Royo A, Eguaras Ros J, Zúñiga Ripa A, Concepción-Martín M, Huelin-Álvarez P, Colán-Hernández J, Cubiella J, Remedios D, Bessa I Caserras X, López-Viedma B, Cobian J, González-Haba M, Santiago J, Martínez-Cara JG, Valdivielso E, Guarner-Argente C; Endoscopic Mucosal Resection Endoscopic Spanish Society Group. A Scoring System to Determine Risk of Delayed Bleeding After Endoscopic Mucosal Resection of Large Colorectal Lesions. Clin Gastroenterol Hepatol. 2016 Aug;14(8):1140-7. doi: 10.1016/j.cgh.2016.03.021. Epub 2016 Mar 24. Erratum in: Clin Gastroenterol Hepatol. 2017 Mar;15(3):469.</citation>
    <PMID>27033428</PMID>
  </results_reference>
  <results_reference>
    <citation>Pohl H, Grimm IS, Moyer MT, Hasan MK, Pleskow D, Elmunzer BJ, Khashab MA, Sanaei O, Al-Kawas FH, Gordon SR, Mathew A, Levenick JM, Aslanian HR, Antaki F, von Renteln D, Crockett SD, Rastogi A, Gill JA, Law RJ, Elias PA, Pellise M, Wallace MB, Mackenzie TA, Rex DK. Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial. Gastroenterology. 2019 Oct;157(4):977-984.e3. doi: 10.1053/j.gastro.2019.03.019. Epub 2019 Mar 15.</citation>
    <PMID>30885778</PMID>
  </results_reference>
  <results_reference>
    <citation>Feagins LA. Colonoscopy, Polypectomy, and the Risk of Bleeding. Med Clin North Am. 2019 Jan;103(1):125-135. doi: 10.1016/j.mcna.2018.08.003. Epub 2018 Nov 1. Review.</citation>
    <PMID>30466669</PMID>
  </results_reference>
  <results_reference>
    <citation>Hassan C, Repici A, Sharma P, Correale L, Zullo A, Bretthauer M, Senore C, Spada C, Bellisario C, Bhandari P, Rex DK. Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis. Gut. 2016 May;65(5):806-20. doi: 10.1136/gutjnl-2014-308481. Epub 2015 Feb 13. Review.</citation>
    <PMID>25681402</PMID>
  </results_reference>
  <results_reference>
    <citation>Burgess NG, Metz AJ, Williams SJ, Singh R, Tam W, Hourigan LF, Zanati SA, Brown GJ, Sonson R, Bourke MJ. Risk factors for intraprocedural and clinically significant delayed bleeding after wide-field endoscopic mucosal resection of large colonic lesions. Clin Gastroenterol Hepatol. 2014 Apr;12(4):651-61.e1-3. doi: 10.1016/j.cgh.2013.09.049. Epub 2013 Oct 1.</citation>
    <PMID>24090728</PMID>
  </results_reference>
  <results_reference>
    <citation>Forbes N, Frehlich L, James MT, Hilsden RJ, Kaplan GG, Wilson TA, Lorenzetti DL, Tate DJ, Bourke MJ, Heitman SJ. Routine Prophylactic Endoscopic Clipping Is Not Efficacious in the Prevention of Delayed Post-Polypectomy Bleeding: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Can Assoc Gastroenterol. 2019 Aug;2(3):105-117. doi: 10.1093/jcag/gwy033. Epub 2018 Jul 20.</citation>
    <PMID>31294373</PMID>
  </results_reference>
  <results_reference>
    <citation>Albéniz E, Álvarez MA, Espinós JC, Nogales O, Guarner C, Alonso P, Rodríguez-Téllez M, Herreros de Tejada A, Santiago J, Bustamante-Balén M, Rodríguez Sánchez J, Ramos-Zabala F, Valdivielso E, Martínez-Alcalá F, Fraile M, Elosua A, Guerra Veloz MF, Ibáñez Beroiz B, Capdevila F, Enguita-Germán M. Clip Closure After Resection of Large Colorectal Lesions With Substantial Risk of Bleeding. Gastroenterology. 2019 Nov;157(5):1213-1221.e4. doi: 10.1053/j.gastro.2019.07.037. Epub 2019 Jul 27.</citation>
    <PMID>31362007</PMID>
  </results_reference>
  <results_reference>
    <citation>Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013 Mar;17(10):1-79. doi: 10.3310/hta17100.</citation>
    <PMID>23477634</PMID>
  </results_reference>
  <results_reference>
    <citation>WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017 May 27;389(10084):2105-2116. doi: 10.1016/S0140-6736(17)30638-4. Epub 2017 Apr 26. Erratum in: Lancet. 2017 May 27;389(10084):2104.</citation>
    <PMID>28456509</PMID>
  </results_reference>
  <results_reference>
    <citation>Bennett C, Klingenberg SL, Langholz E, Gluud LL. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2014 Nov 21;(11):CD006640. doi: 10.1002/14651858.CD006640.pub3. Review.</citation>
    <PMID>25414987</PMID>
  </results_reference>
  <results_reference>
    <citation>Smith SR, Murray D, Pockney PG, Bendinelli C, Draganic BD, Carroll R. Tranexamic Acid for Lower GI Hemorrhage: A Randomized Placebo-Controlled Clinical Trial. Dis Colon Rectum. 2018 Jan;61(1):99-106. doi: 10.1097/DCR.0000000000000943.</citation>
    <PMID>29215478</PMID>
  </results_reference>
  <results_reference>
    <citation>Grass F, Braafladt S, Alabbad J, Lovely JK, Kelley SR, Mathis KL, Huebner M, Larson DW. The effects of tranexamic acid on blood loss and transfusion rate in colorectal surgery. Am J Surg. 2019 Nov;218(5):876-880. doi: 10.1016/j.amjsurg.2019.03.013. Epub 2019 Mar 15.</citation>
    <PMID>30926155</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 10, 2020</study_first_submitted>
  <study_first_submitted_qc>September 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2020</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University</investigator_affiliation>
    <investigator_full_name>Lawrence Charles Hookey</investigator_full_name>
    <investigator_title>Director, Endoscopy</investigator_title>
  </responsible_party>
  <keyword>Endoscopic Mucosal Resection (EMR)</keyword>
  <keyword>Tranexamic Acid</keyword>
  <keyword>Colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

